X-150730161-G-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001306144.3(MTMR1):c.608G>A(p.Gly203Glu) variant causes a missense change. The variant allele was found at a frequency of 0.0000141 in 1,203,740 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 5 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001306144.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000897 AC: 1AN: 111522Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 33722
GnomAD4 exome AF: 0.0000146 AC: 16AN: 1092218Hom.: 0 Cov.: 28 AF XY: 0.0000140 AC XY: 5AN XY: 358376
GnomAD4 genome AF: 0.00000897 AC: 1AN: 111522Hom.: 0 Cov.: 22 AF XY: 0.00 AC XY: 0AN XY: 33722
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 26, 2024 | The c.584G>A (p.G195E) alteration is located in exon 6 (coding exon 6) of the MTMR1 gene. This alteration results from a G to A substitution at nucleotide position 584, causing the glycine (G) at amino acid position 195 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at